Premium
IN8bio Inc (INAB)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.
INB-100 continues to demonstrate durable complete remissions (CR) with no relapses observed in any acute myeloid leukemia (AML) patients including those with high-risk disease after a median...
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that...
50% of patients who received repeated doses (n=10) remained alive and in remission beyond the expected median overall survival (OS) from standard-of-care Stupp regimen while none of the patients...
Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a...
Plenary Oral Presentation at SNO will provide latest clinical trial results from the previously enrolled INB-200 studies of autologous gamma-delta T cells for newly diagnosed glioblastoma (GBM...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0422 | -14.4421629021 | 0.2922 | 0.3164 | 0.24 | 413108 | 0.26835529 | CS |
| 4 | -0.07 | -21.875 | 0.32 | 0.41 | 0.24 | 689200 | 0.32446998 | CS |
| 12 | -0.035 | -12.2807017544 | 0.285 | 0.5566 | 0.217 | 1259479 | 0.37858986 | CS |
| 26 | -0.74 | -74.7474747475 | 0.99 | 0.999 | 0.217 | 721365 | 0.41209241 | CS |
| 52 | -1.25 | -83.3333333333 | 1.5 | 1.93 | 0.217 | 544701 | 0.67137332 | CS |
| 156 | -5.66 | -95.7698815567 | 5.91 | 6.79 | 0.217 | 685641 | 2.0582461 | CS |
| 260 | -9.75 | -97.5 | 10 | 10.319 | 0.217 | 611656 | 2.1137244 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
